The FDA's Ophthalmic Devices Panel issues a mixed vote on the efficacy of AcuFocus's Kamra intraocular implant in improving near-vision in patients with presbyopia.
A panel of FDA experts today was divided on whether the federal watchdog agency should approve the AcuFocus Kamra Inlay, a 1st-of-a-kind permanent corneal implant for the improvement of near and intermediate vision in patients with presbyopia, a form of age-related far-sightedness.
News Well, Regulatory/Clearance, Food & Drug Administration (FDA), Optical/Ophthalmic, Pre-Market Approval (PMA)
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1kETrzi
Cap comentari:
Publica un comentari a l'entrada